TWA
ZVRA icon

TCI Wealth Advisors’s Zevra Therapeutics ZVRA Stock Holding History

TCI Wealth Advisors’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100
Closed -$550 – 2310
2023
Q1 		$550 Hold
100
– – ﹤0.01% 2203
2022
Q4 		$459 Hold
100
– – ﹤0.01% 2222
2022
Q3 		$1K Hold
100
– – ﹤0.01% 2190
2022
Q2 		$0 Hold
100
– – ﹤0.01% 2551
2022
Q1 		$1K Hold
100
– – ﹤0.01% 2169
2021
Q4 		$1K Hold
100
– – ﹤0.01% 2256
2021
Q3 		$1K Hold
100
– – ﹤0.01% 2329
2021
Q2 		$1K Hold
100
– – ﹤0.01% 2269
2021
Q1 		$1K Buy
+100
New +$873 ﹤0.01% 2125

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MAM
Mystic Asset Management Warwick, Rhode Island $431M AUM 25.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return